[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356320-105":59,"doc-detail-356320-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epithelial-cellspecific-prognostic-signature-fth1-rit1-wasl-ndrg2-kifc3-stratifies-cervical-cancer-patients-and-correlates-with-immune-infiltration","Epithelial Cell–Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration","","Cervical cancer remains a leading female malignancy, driven by human papillomavirus targeting epithelial cells that shape tumor behavior and the immune microenvironment. This study builds an epithelial cell (EpC)-specific risk model to improve clinical outcome prediction and clarify immune infiltration changes in cervical cancer. Single-cell RNA-seq processing identifies EpC heterogeneity, while coexpression module discovery and Cox/LASSO modeling generate a five-gene signature (FTH1, RIT1, WASL, NDRG2, KIFC3). The signature stratifies patients into distinct survival and immune infiltration patterns and links risk to chemotherapy sensitivity, with functional validation supporting FTH1 roles in tumor cell proliferation, migration, invasion, and apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epithelial-cellspecific-prognostic-signature-fth1-rit1-wasl-ndrg2-kifc3-stratifies-cervical-cancer-patients-and-correlates-with-immune-infiltration/356320/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epithelial-cellspecific-prognostic-signature-fth1-rit1-wasl-ndrg2-kifc3-stratifies-cervical-cancer-patients-and-correlates-with-immune-infiltration/356320.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the epithelial cell-specific risk model in this study?","Question",{"text":112,"@type":113},"To stratify cervical cancer patients by prognosis using an EpC-specific gene signature and to relate the risk groups to alterations in the tumor immune microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes form the five-gene prognostic signature?",{"text":117,"@type":113},"FTH1, RIT1, WASL, NDRG2, and KIFC3 are combined into a Riskscore model for prognostic stratification.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the risk score relate to immune infiltration and treatment sensitivity?",{"text":121,"@type":113},"High-risk patients show lower immune/stromal scores and distinct immune cell infiltration patterns, and the Riskscore correlates with sensitivity to multiple chemotherapeutic agents.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356320,1790195019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Wiley  \nHuman Mutation  \nVolume 2026, Article ID 4109928, 29 pages [https://doi.org/10.1155/humu/4109928](https://doi.org/10.1155/humu/4109928)  \nResearch Article  \nEpithelial Cell–Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration  \nXuegu Wang , 1 Xingchen Pan ,2 Xiang Li ,3 Biao Ding , 1 Zhixin Jin ,4  \nXiaojing Wang ,4 and Chengli Dou 3  \n1Department of Obstetrics and Gynecology (Center for Reproductive Medicine), The First Aﬃliated Hospital of Bengbu Medical University, Bengbu, China  \n2School of Life Sciences, Bengbu Medical College, Bengbu, China  \n3Molecular Diagnostic Center, The First Aﬃliated Hospital of Bengbu Medical University, Bengbu, China  \n4Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Bengbu, China  \nCorrespondence should be addressed to Xiaojing Wang; wangxiaojing8888@163.com and Chengli Dou; [hzaudou2018@163.com](hzaudou2018@163.com)[ ](hzaudou2018@163.com)Received 22 May 2025; Revised 28 November 2025; Accepted 18 December 2025  \nGuest Editor: Sujit Nair  \nCopyright © 2026 Xuegu Wang et al. Human Mutation published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nBackground: Cervical cancer (CC) remains one of the leading female malignancies. Epithelial cells (EpCs), primarily derived from the cervical squamous and glandular epithelium, are targeted by human papillomavirus to drive CC. Herein, we aimed to develop an EpC-speciﬁc risk model to improve clinical outcomes and unravel tumor immune microenvironment alterations in CC.  \nMethods: scRNA-seq data from GSE208653 were processed using Seurat (including SCTransform for normalization and Harmony for batch correction) . EpC heterogeneity was analyzed via subclustering, pseudotime trajectory analysis with monocle2, and cell–cell communication inference with CellChat. The hdWGCNA package identiﬁed EpC-speciﬁc coexpression modules. Prognostic genes were screened by univariate Cox and LASSO regression, and a Riskscore model was built using multivariate Cox regression. Immune inﬁltration was assessed by ssGSEA, MCPCounter, and ESTIMATE algorithms. Drug sensitivity correlation was analyzed using pRRophetic. In vitro functional assays validated key gene roles in CC cells.  \nResults: Forty thousand four hundred ﬁfty-seven cells were annotated into eight cell populations with a lower percentage of EpCs. Thereafter, EpCs were categorized into three subclusters with speciﬁcally highly expressed genes in peculiar biological pathways and with distinct trajectories of fate. A strong cell–cell communication network was observed, particularly involving Ep C3 and immune cells, via ligand–receptor pairs such as LGALS9-CD44 and HBEGF-EGFR. The hdWGCNA analysis revealed Ep C3– speciﬁc gene modules, from which a ﬁve-gene prognostic signature (FTH1, RIT1, WASL, NDRG2, and KIFC3) was constructed. The resulting risk model eﬀectively stratiﬁed patients into high-and low-risk groups with signiﬁcantly diﬀerent overall survival in both TCGA-CESC and GSE52903 cohorts, supported by time-dependent ROC curves. The high-risk group exhibited lower immune/stromal scores and distinct immune cell inﬁltration patterns. The risk score signiﬁcantly correlated with sensitivity to several chemotherapeutic agents. Crucially, in vitro experiments conﬁrmed that FTH1 knockdown inhibited the proliferation, migration, and invasion of CC cells while enhancing the level of apoptosis in cancer cells.  \nConclusion: A proposed EpC-speciﬁc gene signature for CC may be applicable to support clinical decision-making.  \nKeywords: cervical cancer; computational analyses; epithelial cell; prognostic biomarker; Riskscore model  \n2 Human Mutation  \n1. Introduction 2. Methods  \nCervical cancer (CC) remains a ","cbCaibzEdfuLyTQV","https://ap.wps.com/l/cbCaibzEdfuLyTQV","pdf",6684260,29,"English","# Background\n# Methods\n## Data source and preprocessing\n## scRNA-seq analysis and modeling\n## Immune infiltration and drug sensitivity\n# Results\n## Cell populations and EpC subclusters\n## Prognostic signature and risk stratification\n## Immune infiltration and chemotherapy sensitivity\n# Conclusion","[{\"question\":\"What is the purpose of the epithelial cell-specific risk model in this study?\",\"answer\":\"To stratify cervical cancer patients by prognosis using an EpC-specific gene signature and to relate the risk groups to alterations in the tumor immune microenvironment.\"},{\"question\":\"Which genes form the five-gene prognostic signature?\",\"answer\":\"FTH1, RIT1, WASL, NDRG2, and KIFC3 are combined into a Riskscore model for prognostic stratification.\"},{\"question\":\"How does the risk score relate to immune infiltration and treatment sensitivity?\",\"answer\":\"High-risk patients show lower immune/stromal scores and distinct immune cell infiltration patterns, and the Riskscore correlates with sensitivity to multiple chemotherapeutic agents.\"}]","Epithelial Cell–Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration | PDF",1790124692,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/681730b1696659fdd0f5e83e24bab1c8.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5156e6ebc5123b497146dc4d8e46ec79.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be1ca90b8d7ee6131d45f8afbf23516e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a913c4681b6eb29ae7edac1c30b84764.webp",980,1306]